The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication
Authors:
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 84 (3) , 587-595
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
This publication has 116 references indexed in Scilit:
- Expression Patterns of the Immunosuppressive Proteins PD-1/CD279 and PD-L1/CD274 at Different Stages of Cutaneous T-Cell Lymphoma/Mycosis FungoidesThe American Journal of Dermatopathology, 2012
- The Transcription Factor STAT3 Is Required for T Helper 2 Cell DevelopmentImmunity, 2011
- Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsBlood, 2010
- Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphomaArchives of Dermatological Research, 2010
- Transcriptional regulation of Th2 cell differentiationImmunology & Cell Biology, 2010
- B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disordersBlood, 2009
- Staphylococcus aureusSuperantigens Elicit Redundant and Extensive Human Vβ PatternsInfection and Immunity, 2009
- Administration of oral vitamin D induces cathelicidin production in atopic individualsJournal of Allergy and Clinical Immunology, 2008
- IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytesBlood, 2008
- Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxinsBlood, 2006